NCT01748695View on ClinicalTrials.gov

A Safety, Tolerability and Efficacy Study of V158866 in Central Neuropathic Pain Following Spinal Cord Injury

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Neuropathic Pain Due to Spinal Cord Injury
Interventions
DRUG

V158866

DRUG

Placebo

Trial Locations (1)

02115

Translational Pain Research, Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

Vernalis (R&D) Ltd

INDUSTRY

lead

Brigham and Women's Hospital

OTHER

NCT01748695 - A Safety, Tolerability and Efficacy Study of V158866 in Central Neuropathic Pain Following Spinal Cord Injury | Biotech Hunter | Biotech Hunter